Source: MarketScreener

Idera: Idera Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4)

(marketscreener.com) Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1. ...https://www.marketscreener.com/quote/stock/IDERA-PHARMACEUTICALS-IN-45166572/news/Idera-Pharmaceuticals-Statement-of-Changes-in-Beneficial-Ownership-Form-4-40912983/?utm_medium=RSS&utm_content=20220706

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
John Taylor's photo - CEO of Idera

CEO

John Taylor

CEO Approval Rating

82/100

Read more